# Step 151 - Life-Sciences Assurance Environment Register

**Step 151 is a life-sciences assurance environment register. It does not prove implementation, production readiness, regulatory validation, or operational release.**

This register maps the controlled Assurance OS architecture into priority life-sciences operating environments while preserving the ownership, authority, source-of-truth, and display boundaries established through Steps 149 and 150.

## Locked operating doctrine

- Platform B v1 remains ARCHITECTURE LOCKED.
- Thread D v1 remains ARCHITECTURE LOCKED.
- Platform B1 may evaluate advanced assurance state without reopening Platform B v1.
- Thread D and Thread D2 remain DISPLAY / WITNESS ONLY.
- RAMAT Vision does not approve, release, override, execute, or become evidence authority.
- Qualified humans and authorized organizational roles remain accountable.
- Official records remain in governed source systems.
- Simulator-first, mock-data-first, and local-validation-first controls remain mandatory.
- No PHI, company production data, or real regulated production integration is authorized by this register.

## First-tier commercialization and demonstration tracks

The following environments are preserved as equal first-tier priorities:

- Radiopharmaceutical and IRLT Operations
- Compounding Pharmacy Operations
- DSCSA and Pharmaceutical Supply Chain

## Strategic-priority summary

| Strategic priority | Environment count |
|---|---:|
| CORE LIFE-SCIENCES ASSURANCE | 6 |
| FIRST-TIER COMMERCIALIZATION / DEMONSTRATION | 3 |
| FUTURE CONTROLLED EXTENSION | 1 |
| SUPPORTING REGULATED INFRASTRUCTURE | 4 |

## Environment register

| ID | Environment | Category | Strategic priority | Commercialization track | Status |
|---|---|---|---|---|---|
| ENV-001 | Clinical Trials and Clinical Operations | CLINICAL RESEARCH | CORE LIFE-SCIENCES ASSURANCE | CLINICAL ASSURANCE DEMONSTRATION | REGISTERED LIFE-SCIENCES ASSURANCE BASELINE |
| ENV-002 | GxP Laboratory, LIMS, Middleware, and Instrument Workflows | LABORATORY ASSURANCE | CORE LIFE-SCIENCES ASSURANCE | LABORATORY WORKFLOW DEPENDENCY DEMONSTRATION | REGISTERED LIFE-SCIENCES ASSURANCE BASELINE |
| ENV-003 | GMP Manufacturing, Batch Execution, and MES | MANUFACTURING ASSURANCE | CORE LIFE-SCIENCES ASSURANCE | BATCH AND MES ASSURANCE DEMONSTRATION | REGISTERED LIFE-SCIENCES ASSURANCE BASELINE |
| ENV-004 | Radiopharmaceutical and IRLT Operations | RADIOPHARMACEUTICAL ASSURANCE | FIRST-TIER COMMERCIALIZATION / DEMONSTRATION | IRLT FIRST-TIER TRACK | REGISTERED LIFE-SCIENCES ASSURANCE BASELINE |
| ENV-005 | Compounding Pharmacy Operations | COMPOUNDING PHARMACY ASSURANCE | FIRST-TIER COMMERCIALIZATION / DEMONSTRATION | COMPOUNDING PHARMACY FIRST-TIER TRACK | REGISTERED LIFE-SCIENCES ASSURANCE BASELINE |
| ENV-006 | DSCSA and Pharmaceutical Supply Chain | SUPPLY-CHAIN ASSURANCE | FIRST-TIER COMMERCIALIZATION / DEMONSTRATION | DSCSA FIRST-TIER TRACK | REGISTERED LIFE-SCIENCES ASSURANCE BASELINE |
| ENV-007 | CMC, Process Development, and Technology Transfer | CMC ASSURANCE | CORE LIFE-SCIENCES ASSURANCE | AI-ENABLED CMC ASSURANCE TRACK | REGISTERED LIFE-SCIENCES ASSURANCE BASELINE |
| ENV-008 | Quality Systems, Deviations, CAPA, Change Control, and Validation | QUALITY-SYSTEM ASSURANCE | CORE LIFE-SCIENCES ASSURANCE | QUALITY EVENT AND GOVERNANCE TRACK | REGISTERED LIFE-SCIENCES ASSURANCE BASELINE |
| ENV-009 | Facilities, Utilities, BMS, and Environmental Monitoring | FACILITIES AND ENVIRONMENTAL ASSURANCE | SUPPORTING REGULATED INFRASTRUCTURE | FACILITY AND ENVIRONMENT ASSURANCE TRACK | REGISTERED LIFE-SCIENCES ASSURANCE BASELINE |
| ENV-010 | Equipment, Calibration, Preventive Maintenance, and Asset Assurance | EQUIPMENT AND ASSET ASSURANCE | SUPPORTING REGULATED INFRASTRUCTURE | EQUIPMENT DEPENDENCY ASSURANCE TRACK | REGISTERED LIFE-SCIENCES ASSURANCE BASELINE |
| ENV-011 | Automation, Historian, OT, Edge, and Device Witness | AUTOMATION AND OT ASSURANCE | SUPPORTING REGULATED INFRASTRUCTURE | AUTOMATION TRUTH ASSURANCE TRACK | REGISTERED LIFE-SCIENCES ASSURANCE BASELINE |
| ENV-012 | Regulatory Submission and AI-Native Inspection Readiness | REGULATORY AND INSPECTION ASSURANCE | CORE LIFE-SCIENCES ASSURANCE | REGULATORY AI INSPECTION PASSPORT TRACK | REGISTERED LIFE-SCIENCES ASSURANCE BASELINE |
| ENV-013 | Enterprise GxP IT, CMDB, Identity, ServiceNow, and Cybersecurity | ENTERPRISE GXP IT ASSURANCE | SUPPORTING REGULATED INFRASTRUCTURE | CITRUST AND ENTERPRISE ASSURANCE TRACK | REGISTERED LIFE-SCIENCES ASSURANCE BASELINE |
| ENV-014 | Healthcare and Patient-Support AI | HEALTHCARE AI ASSURANCE | FUTURE CONTROLLED EXTENSION | HEALTHCARE ASSURANCE EXTENSION TRACK | REGISTERED LIFE-SCIENCES ASSURANCE BASELINE |

## Environment assurance details

### ENV-001 - Clinical Trials and Clinical Operations

- Category: CLINICAL RESEARCH
- Strategic priority: **CORE LIFE-SCIENCES ASSURANCE**
- Commercialization track: CLINICAL ASSURANCE DEMONSTRATION
- Primary assurance problem: Clinical workflows may appear complete while identity, protocol, site, consent, delegation, data provenance, review, and evidence dependencies remain incomplete or inconsistent.
- Key workflow dependencies: Participant identity; informed consent; protocol version; site activation; investigator delegation; randomization; EDC; CTMS; eTMF; safety reporting; laboratory results; data review; monitoring; and submission traceability.
- Evidence sources: Protocol records; consent evidence; delegation logs; EDC audit trails; CTMS milestones; eTMF documents; monitoring evidence; laboratory evidence; safety records; and human review records.
- Official source systems: EDC, CTMS, eTMF, IRT/RTSM, safety systems, laboratory systems, document management systems, and regulated clinical repositories.
- Human authority: Principal investigator, sponsor medical authority, clinical operations, data management, safety personnel, quality assurance, and authorized reviewers.
- Assurance outcomes: Protocol-to-evidence traceability; participant identity integrity; delegation assurance; consent assurance; review completeness; workflow dependency integrity; and inspection reconstruction.
- Representative use cases: Site activation readiness; enrollment admissibility; consent verification; clinical data provenance; protocol deviation reconstruction; AI-assisted trial decision governance; and inspection readiness.

**Architecture application**

- Platform A: Registers the use case, regulated context, stakeholders, risk classification, system inventory, and governance ownership.
- Platform B v1: Uses the frozen six-capability Platform B v1 core for registry, assurance checks, evidence upload, trust scoring, admissibility records, and wearable endpoint simulation where applicable.
- Platform B1 / MVP2: Evaluates advanced assurance conditions such as evidence integrity, workflow dependency integrity, source agreement, identity, authority, No-Bind state, reconstruction, and inspection readiness.
- Thread C / AEBOK: Translates verified lessons into Assurance Engineering doctrine, research, publications, teaching material, and regulated case studies.
- Thread D v1: May display or witness Platform B v1 assurance state through the locked Thread D v1 connector. It has no decision authority.
- Thread D2 / RAMAT Vision: May display Platform B1 evaluated assurance state through RAMAT Vision. It remains preview-only and DISPLAY / WITNESS ONLY.
- Cross-cutting Assurance OS: Uses shared identity, evidence integrity, hashing, rehashing, chain-of-custody, authority, provenance, and governance schemas.

**Mandatory boundaries**

- Decision boundary: Platform B or Platform B1 may evaluate assurance state. Qualified humans and authorized organizational roles make binding decisions.
- Display boundary: Thread D, Thread D2, RAMAT Vision, glasses, wearables, and device witnesses may display or witness state but may not approve, release, override, resolve, or execute regulated work.
- Source-of-truth boundary: Official records remain in governed source systems. COBIT-Chain may reference, hash, seal, evaluate, reconstruct, or display evidence but does not replace the official record.
- Data boundary: Simulator-first, mock-data-first, and local-validation-first. No PHI, company production data, or real regulated production integration is authorized by this register.
- Maturity statement: Environment registration is not implementation proof, production readiness, regulatory validation, or operational release.
- Review status: HUMAN ENVIRONMENT REVIEW REQUIRED

### ENV-002 - GxP Laboratory, LIMS, Middleware, and Instrument Workflows

- Category: LABORATORY ASSURANCE
- Strategic priority: **CORE LIFE-SCIENCES ASSURANCE**
- Commercialization track: LABORATORY WORKFLOW DEPENDENCY DEMONSTRATION
- Primary assurance problem: A result may appear complete in one component while remaining blocked, held, mismatched, delayed, manually altered, or not defensible across instruments, middleware, LIMS, interfaces, identities, and reviews.
- Key workflow dependencies: Sample identity; accession number; instrument status; calibration; method version; middleware state; interface state; LIMS state; analyst identity; review status; audit trail; result mapping; and release authorization.
- Evidence sources: Instrument files; raw data; middleware logs; LIMS audit trails; sample records; method versions; calibration evidence; analyst actions; exception logs; interface messages; and review records.
- Official source systems: LIMS, laboratory middleware, CDS, instrument software, SDMS, ELN, validated file stores, and approved quality systems.
- Human authority: Qualified analyst, laboratory reviewer, laboratory management, system owner, data integrity owner, and Quality Unit.
- Assurance outcomes: Sample-to-result genealogy; source agreement; interface dependency assurance; result hold visibility; identity integrity; audit-trail completeness; and defensible result reconstruction.
- Representative use cases: LIS/middleware mismatch; verified result held in LIMS; manual result-entry error; patient or accession mismatch; interface timeout; missing audit fields; instrument server latency; and site-to-site workflow variation.

**Architecture application**

- Platform A: Registers the use case, regulated context, stakeholders, risk classification, system inventory, and governance ownership.
- Platform B v1: Uses the frozen six-capability Platform B v1 core for registry, assurance checks, evidence upload, trust scoring, admissibility records, and wearable endpoint simulation where applicable.
- Platform B1 / MVP2: Evaluates advanced assurance conditions such as evidence integrity, workflow dependency integrity, source agreement, identity, authority, No-Bind state, reconstruction, and inspection readiness.
- Thread C / AEBOK: Translates verified lessons into Assurance Engineering doctrine, research, publications, teaching material, and regulated case studies.
- Thread D v1: May display or witness Platform B v1 assurance state through the locked Thread D v1 connector. It has no decision authority.
- Thread D2 / RAMAT Vision: May display Platform B1 evaluated assurance state through RAMAT Vision. It remains preview-only and DISPLAY / WITNESS ONLY.
- Cross-cutting Assurance OS: Uses shared identity, evidence integrity, hashing, rehashing, chain-of-custody, authority, provenance, and governance schemas.

**Mandatory boundaries**

- Decision boundary: Platform B or Platform B1 may evaluate assurance state. Qualified humans and authorized organizational roles make binding decisions.
- Display boundary: Thread D, Thread D2, RAMAT Vision, glasses, wearables, and device witnesses may display or witness state but may not approve, release, override, resolve, or execute regulated work.
- Source-of-truth boundary: Official records remain in governed source systems. COBIT-Chain may reference, hash, seal, evaluate, reconstruct, or display evidence but does not replace the official record.
- Data boundary: Simulator-first, mock-data-first, and local-validation-first. No PHI, company production data, or real regulated production integration is authorized by this register.
- Maturity statement: Environment registration is not implementation proof, production readiness, regulatory validation, or operational release.
- Review status: HUMAN ENVIRONMENT REVIEW REQUIRED

### ENV-003 - GMP Manufacturing, Batch Execution, and MES

- Category: MANUFACTURING ASSURANCE
- Strategic priority: **CORE LIFE-SCIENCES ASSURANCE**
- Commercialization track: BATCH AND MES ASSURANCE DEMONSTRATION
- Primary assurance problem: Manufacturing execution may progress while material, equipment, recipe, operator, environmental, automation, review, or release dependencies are incomplete, mismatched, or not evidence-defensible.
- Key workflow dependencies: Master batch record; recipe version; material status; equipment status; operator qualification; line clearance; environmental state; automation state; deviation status; review by exception; and batch release dependencies.
- Evidence sources: Electronic batch records; MES events; equipment records; material genealogy; operator actions; environmental evidence; automation events; deviations; review records; and release evidence.
- Official source systems: MES, ERP, LIMS, eQMS, historian, automation platforms, equipment systems, warehouse systems, and validated document repositories.
- Human authority: Manufacturing operators, manufacturing supervision, process engineering, system owners, quality reviewers, and authorized batch-release personnel.
- Assurance outcomes: Batch release dependency assurance; MES execution dependency assurance; material genealogy assurance; equipment-state assurance; review completeness; and end-to-end batch evidence reconstruction.
- Representative use cases: Pre-execution readiness; recipe-version mismatch; equipment hold; material-status conflict; missing operator qualification; exception review; deviation linkage; and batch-release readiness.

**Architecture application**

- Platform A: Registers the use case, regulated context, stakeholders, risk classification, system inventory, and governance ownership.
- Platform B v1: Uses the frozen six-capability Platform B v1 core for registry, assurance checks, evidence upload, trust scoring, admissibility records, and wearable endpoint simulation where applicable.
- Platform B1 / MVP2: Evaluates advanced assurance conditions such as evidence integrity, workflow dependency integrity, source agreement, identity, authority, No-Bind state, reconstruction, and inspection readiness.
- Thread C / AEBOK: Translates verified lessons into Assurance Engineering doctrine, research, publications, teaching material, and regulated case studies.
- Thread D v1: May display or witness Platform B v1 assurance state through the locked Thread D v1 connector. It has no decision authority.
- Thread D2 / RAMAT Vision: May display Platform B1 evaluated assurance state through RAMAT Vision. It remains preview-only and DISPLAY / WITNESS ONLY.
- Cross-cutting Assurance OS: Uses shared identity, evidence integrity, hashing, rehashing, chain-of-custody, authority, provenance, and governance schemas.

**Mandatory boundaries**

- Decision boundary: Platform B or Platform B1 may evaluate assurance state. Qualified humans and authorized organizational roles make binding decisions.
- Display boundary: Thread D, Thread D2, RAMAT Vision, glasses, wearables, and device witnesses may display or witness state but may not approve, release, override, resolve, or execute regulated work.
- Source-of-truth boundary: Official records remain in governed source systems. COBIT-Chain may reference, hash, seal, evaluate, reconstruct, or display evidence but does not replace the official record.
- Data boundary: Simulator-first, mock-data-first, and local-validation-first. No PHI, company production data, or real regulated production integration is authorized by this register.
- Maturity statement: Environment registration is not implementation proof, production readiness, regulatory validation, or operational release.
- Review status: HUMAN ENVIRONMENT REVIEW REQUIRED

### ENV-004 - Radiopharmaceutical and IRLT Operations

- Category: RADIOPHARMACEUTICAL ASSURANCE
- Strategic priority: **FIRST-TIER COMMERCIALIZATION / DEMONSTRATION**
- Commercialization track: IRLT FIRST-TIER TRACK
- Primary assurance problem: Short-lived radiopharmaceutical workflows require tightly synchronized identity, timing, dose, material, equipment, laboratory, transport, release, and patient-treatment dependencies.
- Key workflow dependencies: Isotope receipt; radionuclide identity; decay timing; synthesis; equipment status; environmental status; QC completion; sterility dependencies; dose calculation; batch release; chain of identity; chain of custody; transport; and administration window.
- Evidence sources: Isotope records; synthesis evidence; batch records; laboratory results; equipment evidence; environmental evidence; dose records; release records; transport evidence; timestamps; custody events; and administration evidence.
- Official source systems: MES or batch systems, LIMS, dose-management systems, ERP, eQMS, equipment systems, logistics systems, clinical systems, and approved records.
- Human authority: Authorized nuclear pharmacist, qualified manufacturing personnel, laboratory staff, Quality Unit, radiation safety personnel, clinical authority, and authorized releaser.
- Assurance outcomes: Chain-of-identity truth; chain-of-custody truth; timing assurance; release dependency assurance; dose evidence integrity; material genealogy; and patient-treatment readiness.
- Representative use cases: Time-critical batch release; dose-to-patient identity; isotope decay window; transport readiness; laboratory dependency hold; equipment readiness; and regulator inspection reconstruction.

**Architecture application**

- Platform A: Registers the use case, regulated context, stakeholders, risk classification, system inventory, and governance ownership.
- Platform B v1: Uses the frozen six-capability Platform B v1 core for registry, assurance checks, evidence upload, trust scoring, admissibility records, and wearable endpoint simulation where applicable.
- Platform B1 / MVP2: Evaluates advanced assurance conditions such as evidence integrity, workflow dependency integrity, source agreement, identity, authority, No-Bind state, reconstruction, and inspection readiness.
- Thread C / AEBOK: Translates verified lessons into Assurance Engineering doctrine, research, publications, teaching material, and regulated case studies.
- Thread D v1: May display or witness Platform B v1 assurance state through the locked Thread D v1 connector. It has no decision authority.
- Thread D2 / RAMAT Vision: May display Platform B1 evaluated assurance state through RAMAT Vision. It remains preview-only and DISPLAY / WITNESS ONLY.
- Cross-cutting Assurance OS: Uses shared identity, evidence integrity, hashing, rehashing, chain-of-custody, authority, provenance, and governance schemas.

**Mandatory boundaries**

- Decision boundary: Platform B or Platform B1 may evaluate assurance state. Qualified humans and authorized organizational roles make binding decisions.
- Display boundary: Thread D, Thread D2, RAMAT Vision, glasses, wearables, and device witnesses may display or witness state but may not approve, release, override, resolve, or execute regulated work.
- Source-of-truth boundary: Official records remain in governed source systems. COBIT-Chain may reference, hash, seal, evaluate, reconstruct, or display evidence but does not replace the official record.
- Data boundary: Simulator-first, mock-data-first, and local-validation-first. No PHI, company production data, or real regulated production integration is authorized by this register.
- Maturity statement: Environment registration is not implementation proof, production readiness, regulatory validation, or operational release.
- Review status: HUMAN ENVIRONMENT REVIEW REQUIRED

### ENV-005 - Compounding Pharmacy Operations

- Category: COMPOUNDING PHARMACY ASSURANCE
- Strategic priority: **FIRST-TIER COMMERCIALIZATION / DEMONSTRATION**
- Commercialization track: COMPOUNDING PHARMACY FIRST-TIER TRACK
- Primary assurance problem: Compounded preparations require defensible agreement across prescription, formula, ingredients, lot identity, beyond-use dating, environment, personnel, equipment, preparation, verification, labeling, release, and dispensing.
- Key workflow dependencies: Prescription or order; master formulation record; ingredient identity; lot status; supplier status; weighing; environmental state; personnel qualification; equipment status; compounding record; verification; labeling; BUD; storage; release; and dispensing.
- Evidence sources: Prescription records; formulation records; certificates; lot records; weighing evidence; environmental records; training records; equipment evidence; preparation records; verification evidence; labels; release records; and dispensing evidence.
- Official source systems: Pharmacy management systems, compounding systems, inventory systems, eQMS, environmental systems, equipment systems, and controlled document repositories.
- Human authority: Licensed pharmacist, compounding personnel, designated verifier, pharmacy management, quality personnel, and authorized release roles.
- Assurance outcomes: Prescription-to-preparation traceability; ingredient genealogy; formulation integrity; environmental assurance; personnel qualification assurance; label accuracy; BUD defensibility; and dispensing evidence integrity.
- Representative use cases: Sterile compounding readiness; formula-version verification; ingredient-lot genealogy; environmental excursion hold; pharmacist verification; label mismatch; beyond-use-date assurance; and recall reconstruction.

**Architecture application**

- Platform A: Registers the use case, regulated context, stakeholders, risk classification, system inventory, and governance ownership.
- Platform B v1: Uses the frozen six-capability Platform B v1 core for registry, assurance checks, evidence upload, trust scoring, admissibility records, and wearable endpoint simulation where applicable.
- Platform B1 / MVP2: Evaluates advanced assurance conditions such as evidence integrity, workflow dependency integrity, source agreement, identity, authority, No-Bind state, reconstruction, and inspection readiness.
- Thread C / AEBOK: Translates verified lessons into Assurance Engineering doctrine, research, publications, teaching material, and regulated case studies.
- Thread D v1: May display or witness Platform B v1 assurance state through the locked Thread D v1 connector. It has no decision authority.
- Thread D2 / RAMAT Vision: May display Platform B1 evaluated assurance state through RAMAT Vision. It remains preview-only and DISPLAY / WITNESS ONLY.
- Cross-cutting Assurance OS: Uses shared identity, evidence integrity, hashing, rehashing, chain-of-custody, authority, provenance, and governance schemas.

**Mandatory boundaries**

- Decision boundary: Platform B or Platform B1 may evaluate assurance state. Qualified humans and authorized organizational roles make binding decisions.
- Display boundary: Thread D, Thread D2, RAMAT Vision, glasses, wearables, and device witnesses may display or witness state but may not approve, release, override, resolve, or execute regulated work.
- Source-of-truth boundary: Official records remain in governed source systems. COBIT-Chain may reference, hash, seal, evaluate, reconstruct, or display evidence but does not replace the official record.
- Data boundary: Simulator-first, mock-data-first, and local-validation-first. No PHI, company production data, or real regulated production integration is authorized by this register.
- Maturity statement: Environment registration is not implementation proof, production readiness, regulatory validation, or operational release.
- Review status: HUMAN ENVIRONMENT REVIEW REQUIRED

### ENV-006 - DSCSA and Pharmaceutical Supply Chain

- Category: SUPPLY-CHAIN ASSURANCE
- Strategic priority: **FIRST-TIER COMMERCIALIZATION / DEMONSTRATION**
- Commercialization track: DSCSA FIRST-TIER TRACK
- Primary assurance problem: Pharmaceutical products require interoperable, defensible transaction, serialization, verification, ownership, custody, exception, and recall evidence across trading partners and systems.
- Key workflow dependencies: Product identifier; serial number; lot; expiration; transaction information; transaction statement; trading-partner authorization; verification requests; EPCIS exchange; aggregation; deaggregation; exception management; returns; suspect-product investigation; and recall.
- Evidence sources: Serialization events; EPCIS records; transaction records; verification messages; partner identity; shipping evidence; receiving evidence; exception records; return evidence; investigation evidence; and recall records.
- Official source systems: Serialization platforms, EPCIS repositories, ERP, warehouse systems, distribution systems, partner gateways, verification routers, and quality systems.
- Human authority: Authorized trading-partner personnel, supply-chain owners, quality personnel, investigators, compliance personnel, and recall authorities.
- Assurance outcomes: Product identity integrity; trading-partner assurance; transaction traceability; chain-of-custody truth; exception visibility; suspect-product governance; and recall reconstruction.
- Representative use cases: Serialized-product verification; EPCIS mismatch; unauthorized trading partner; aggregation break; saleable-return verification; suspect-product hold; transaction-history reconstruction; and recall execution evidence.

**Architecture application**

- Platform A: Registers the use case, regulated context, stakeholders, risk classification, system inventory, and governance ownership.
- Platform B v1: Uses the frozen six-capability Platform B v1 core for registry, assurance checks, evidence upload, trust scoring, admissibility records, and wearable endpoint simulation where applicable.
- Platform B1 / MVP2: Evaluates advanced assurance conditions such as evidence integrity, workflow dependency integrity, source agreement, identity, authority, No-Bind state, reconstruction, and inspection readiness.
- Thread C / AEBOK: Translates verified lessons into Assurance Engineering doctrine, research, publications, teaching material, and regulated case studies.
- Thread D v1: May display or witness Platform B v1 assurance state through the locked Thread D v1 connector. It has no decision authority.
- Thread D2 / RAMAT Vision: May display Platform B1 evaluated assurance state through RAMAT Vision. It remains preview-only and DISPLAY / WITNESS ONLY.
- Cross-cutting Assurance OS: Uses shared identity, evidence integrity, hashing, rehashing, chain-of-custody, authority, provenance, and governance schemas.

**Mandatory boundaries**

- Decision boundary: Platform B or Platform B1 may evaluate assurance state. Qualified humans and authorized organizational roles make binding decisions.
- Display boundary: Thread D, Thread D2, RAMAT Vision, glasses, wearables, and device witnesses may display or witness state but may not approve, release, override, resolve, or execute regulated work.
- Source-of-truth boundary: Official records remain in governed source systems. COBIT-Chain may reference, hash, seal, evaluate, reconstruct, or display evidence but does not replace the official record.
- Data boundary: Simulator-first, mock-data-first, and local-validation-first. No PHI, company production data, or real regulated production integration is authorized by this register.
- Maturity statement: Environment registration is not implementation proof, production readiness, regulatory validation, or operational release.
- Review status: HUMAN ENVIRONMENT REVIEW REQUIRED

### ENV-007 - CMC, Process Development, and Technology Transfer

- Category: CMC ASSURANCE
- Strategic priority: **CORE LIFE-SCIENCES ASSURANCE**
- Commercialization track: AI-ENABLED CMC ASSURANCE TRACK
- Primary assurance problem: AI-assisted formulation, process development, digital-twin analysis, CPP/CQA optimization, scale-up, technology transfer, and regulatory content must remain traceable to evidence and qualified human review.
- Key workflow dependencies: Formulation rationale; model identity; training-data provenance; CPP/CQA mapping; digital-twin version; experiment results; process model; scale-up assumptions; technology-transfer package; change control; validation strategy; and human approval.
- Evidence sources: Development reports; model records; experiment data; ELN records; digital-twin evidence; risk assessments; control strategies; transfer protocols; validation records; change controls; and regulatory content review.
- Official source systems: ELN, LIMS, development data platforms, modeling systems, document management systems, eQMS, regulatory information systems, MES, and validated repositories.
- Human authority: Formulation scientists, process scientists, engineers, statisticians, model owners, technology-transfer leads, regulatory personnel, and Quality Unit.
- Assurance outcomes: AI recommendation provenance; claim-to-proof traceability; model-use governance; digital-twin evidence integrity; transfer-package completeness; control-strategy traceability; and defensible regulatory CMC content.
- Representative use cases: AI-selected formulation; AI-optimized CPPs or CQAs; digital-twin-assisted scale-up; AI-generated CMC content; technology-transfer dependency assurance; and lifecycle evidence continuity.

**Architecture application**

- Platform A: Registers the use case, regulated context, stakeholders, risk classification, system inventory, and governance ownership.
- Platform B v1: Uses the frozen six-capability Platform B v1 core for registry, assurance checks, evidence upload, trust scoring, admissibility records, and wearable endpoint simulation where applicable.
- Platform B1 / MVP2: Evaluates advanced assurance conditions such as evidence integrity, workflow dependency integrity, source agreement, identity, authority, No-Bind state, reconstruction, and inspection readiness.
- Thread C / AEBOK: Translates verified lessons into Assurance Engineering doctrine, research, publications, teaching material, and regulated case studies.
- Thread D v1: May display or witness Platform B v1 assurance state through the locked Thread D v1 connector. It has no decision authority.
- Thread D2 / RAMAT Vision: May display Platform B1 evaluated assurance state through RAMAT Vision. It remains preview-only and DISPLAY / WITNESS ONLY.
- Cross-cutting Assurance OS: Uses shared identity, evidence integrity, hashing, rehashing, chain-of-custody, authority, provenance, and governance schemas.

**Mandatory boundaries**

- Decision boundary: Platform B or Platform B1 may evaluate assurance state. Qualified humans and authorized organizational roles make binding decisions.
- Display boundary: Thread D, Thread D2, RAMAT Vision, glasses, wearables, and device witnesses may display or witness state but may not approve, release, override, resolve, or execute regulated work.
- Source-of-truth boundary: Official records remain in governed source systems. COBIT-Chain may reference, hash, seal, evaluate, reconstruct, or display evidence but does not replace the official record.
- Data boundary: Simulator-first, mock-data-first, and local-validation-first. No PHI, company production data, or real regulated production integration is authorized by this register.
- Maturity statement: Environment registration is not implementation proof, production readiness, regulatory validation, or operational release.
- Review status: HUMAN ENVIRONMENT REVIEW REQUIRED

### ENV-008 - Quality Systems, Deviations, CAPA, Change Control, and Validation

- Category: QUALITY-SYSTEM ASSURANCE
- Strategic priority: **CORE LIFE-SCIENCES ASSURANCE**
- Commercialization track: QUALITY EVENT AND GOVERNANCE TRACK
- Primary assurance problem: Quality events may be fragmented across systems, documents, emails, investigations, actions, approvals, effectiveness checks, and linked operational evidence.
- Key workflow dependencies: Event identity; issue detection; containment; impact assessment; investigation; root cause; CAPA; change control; validation; approver authority; due dates; effectiveness checks; closure; and recurrence monitoring.
- Evidence sources: Deviation records; CAPA records; investigation evidence; change controls; validation records; risk assessments; approvals; action evidence; effectiveness checks; audit trails; and linked operational evidence.
- Official source systems: eQMS, document management systems, validation systems, training systems, ServiceNow where governed, laboratory systems, MES, ERP, and approved repositories.
- Human authority: Quality Unit, investigation owners, CAPA owners, change owners, validation personnel, system owners, process owners, and authorized approvers.
- Assurance outcomes: Deviation truth timeline; CAPA evidence continuity; change dependency assurance; approval-authority verification; No-Bind governance; effectiveness-check traceability; and defensible quality-event reconstruction.
- Representative use cases: Missing investigation evidence; overdue CAPA dependency; unavailable approver; silent dashboard; validation evidence gap; change implementation without prerequisites; and inspection reconstruction.

**Architecture application**

- Platform A: Registers the use case, regulated context, stakeholders, risk classification, system inventory, and governance ownership.
- Platform B v1: Uses the frozen six-capability Platform B v1 core for registry, assurance checks, evidence upload, trust scoring, admissibility records, and wearable endpoint simulation where applicable.
- Platform B1 / MVP2: Evaluates advanced assurance conditions such as evidence integrity, workflow dependency integrity, source agreement, identity, authority, No-Bind state, reconstruction, and inspection readiness.
- Thread C / AEBOK: Translates verified lessons into Assurance Engineering doctrine, research, publications, teaching material, and regulated case studies.
- Thread D v1: May display or witness Platform B v1 assurance state through the locked Thread D v1 connector. It has no decision authority.
- Thread D2 / RAMAT Vision: May display Platform B1 evaluated assurance state through RAMAT Vision. It remains preview-only and DISPLAY / WITNESS ONLY.
- Cross-cutting Assurance OS: Uses shared identity, evidence integrity, hashing, rehashing, chain-of-custody, authority, provenance, and governance schemas.

**Mandatory boundaries**

- Decision boundary: Platform B or Platform B1 may evaluate assurance state. Qualified humans and authorized organizational roles make binding decisions.
- Display boundary: Thread D, Thread D2, RAMAT Vision, glasses, wearables, and device witnesses may display or witness state but may not approve, release, override, resolve, or execute regulated work.
- Source-of-truth boundary: Official records remain in governed source systems. COBIT-Chain may reference, hash, seal, evaluate, reconstruct, or display evidence but does not replace the official record.
- Data boundary: Simulator-first, mock-data-first, and local-validation-first. No PHI, company production data, or real regulated production integration is authorized by this register.
- Maturity statement: Environment registration is not implementation proof, production readiness, regulatory validation, or operational release.
- Review status: HUMAN ENVIRONMENT REVIEW REQUIRED

### ENV-009 - Facilities, Utilities, BMS, and Environmental Monitoring

- Category: FACILITIES AND ENVIRONMENTAL ASSURANCE
- Strategic priority: **SUPPORTING REGULATED INFRASTRUCTURE**
- Commercialization track: FACILITY AND ENVIRONMENT ASSURANCE TRACK
- Primary assurance problem: Facility and environmental states may be technically available while alarms, access, calibration, trend, review, communication, or quality dependencies remain unresolved.
- Key workflow dependencies: HVAC state; pressure cascade; temperature; humidity; environmental monitoring; alarms; sensor calibration; access control; historian data; review; maintenance; change control; backup; recovery; and escalation.
- Evidence sources: BMS events; EMS records; alarm histories; trends; access records; calibration records; maintenance evidence; backup evidence; review records; deviations; and change controls.
- Official source systems: BMS, EMS, historian, access-control systems, maintenance systems, eQMS, CMMS, validated file stores, and approved reporting systems.
- Human authority: Facilities personnel, engineering, environmental monitoring staff, system owners, security personnel, maintenance personnel, and Quality Unit.
- Assurance outcomes: Environmental-state assurance; alarm-review completeness; access-accountability assurance; backup evidence integrity; calibration dependency assurance; and facility-event reconstruction.
- Representative use cases: BMS user reconciliation; disabled-account removal; environmental excursion; alarm-review gap; missing backup evidence; sensor calibration hold; and facility change-control readiness.

**Architecture application**

- Platform A: Registers the use case, regulated context, stakeholders, risk classification, system inventory, and governance ownership.
- Platform B v1: Uses the frozen six-capability Platform B v1 core for registry, assurance checks, evidence upload, trust scoring, admissibility records, and wearable endpoint simulation where applicable.
- Platform B1 / MVP2: Evaluates advanced assurance conditions such as evidence integrity, workflow dependency integrity, source agreement, identity, authority, No-Bind state, reconstruction, and inspection readiness.
- Thread C / AEBOK: Translates verified lessons into Assurance Engineering doctrine, research, publications, teaching material, and regulated case studies.
- Thread D v1: May display or witness Platform B v1 assurance state through the locked Thread D v1 connector. It has no decision authority.
- Thread D2 / RAMAT Vision: May display Platform B1 evaluated assurance state through RAMAT Vision. It remains preview-only and DISPLAY / WITNESS ONLY.
- Cross-cutting Assurance OS: Uses shared identity, evidence integrity, hashing, rehashing, chain-of-custody, authority, provenance, and governance schemas.

**Mandatory boundaries**

- Decision boundary: Platform B or Platform B1 may evaluate assurance state. Qualified humans and authorized organizational roles make binding decisions.
- Display boundary: Thread D, Thread D2, RAMAT Vision, glasses, wearables, and device witnesses may display or witness state but may not approve, release, override, resolve, or execute regulated work.
- Source-of-truth boundary: Official records remain in governed source systems. COBIT-Chain may reference, hash, seal, evaluate, reconstruct, or display evidence but does not replace the official record.
- Data boundary: Simulator-first, mock-data-first, and local-validation-first. No PHI, company production data, or real regulated production integration is authorized by this register.
- Maturity statement: Environment registration is not implementation proof, production readiness, regulatory validation, or operational release.
- Review status: HUMAN ENVIRONMENT REVIEW REQUIRED

### ENV-010 - Equipment, Calibration, Preventive Maintenance, and Asset Assurance

- Category: EQUIPMENT AND ASSET ASSURANCE
- Strategic priority: **SUPPORTING REGULATED INFRASTRUCTURE**
- Commercialization track: EQUIPMENT DEPENDENCY ASSURANCE TRACK
- Primary assurance problem: Equipment may be available for use while calibration, maintenance, qualification, configuration, software, ownership, CMDB, or validation dependencies are incomplete.
- Key workflow dependencies: Equipment identity; CI identity; owner; lifecycle status; qualification; validation; calibration; preventive maintenance; firmware; software version; configuration; access; support group; spare parts; and retirement status.
- Evidence sources: Equipment records; CMDB records; calibration certificates; maintenance work orders; qualification evidence; validation evidence; configuration evidence; access records; service records; and lifecycle records.
- Official source systems: CMMS, calibration systems, ServiceNow CMDB, asset systems, validation systems, document repositories, eQMS, and equipment-native systems.
- Human authority: Equipment owner, asset owner, maintenance personnel, calibration personnel, system owner, validation personnel, engineering, and Quality Unit.
- Assurance outcomes: Equipment identity assurance; calibration and PM readiness; lifecycle-state assurance; CMDB relationship integrity; validation dependency assurance; and equipment-use admissibility.
- Representative use cases: Calibration overdue; PM incomplete; duplicate CI; misspelled CI; incorrect owner; missing parent application; unsupported software; validation gap; and retirement mismatch.

**Architecture application**

- Platform A: Registers the use case, regulated context, stakeholders, risk classification, system inventory, and governance ownership.
- Platform B v1: Uses the frozen six-capability Platform B v1 core for registry, assurance checks, evidence upload, trust scoring, admissibility records, and wearable endpoint simulation where applicable.
- Platform B1 / MVP2: Evaluates advanced assurance conditions such as evidence integrity, workflow dependency integrity, source agreement, identity, authority, No-Bind state, reconstruction, and inspection readiness.
- Thread C / AEBOK: Translates verified lessons into Assurance Engineering doctrine, research, publications, teaching material, and regulated case studies.
- Thread D v1: May display or witness Platform B v1 assurance state through the locked Thread D v1 connector. It has no decision authority.
- Thread D2 / RAMAT Vision: May display Platform B1 evaluated assurance state through RAMAT Vision. It remains preview-only and DISPLAY / WITNESS ONLY.
- Cross-cutting Assurance OS: Uses shared identity, evidence integrity, hashing, rehashing, chain-of-custody, authority, provenance, and governance schemas.

**Mandatory boundaries**

- Decision boundary: Platform B or Platform B1 may evaluate assurance state. Qualified humans and authorized organizational roles make binding decisions.
- Display boundary: Thread D, Thread D2, RAMAT Vision, glasses, wearables, and device witnesses may display or witness state but may not approve, release, override, resolve, or execute regulated work.
- Source-of-truth boundary: Official records remain in governed source systems. COBIT-Chain may reference, hash, seal, evaluate, reconstruct, or display evidence but does not replace the official record.
- Data boundary: Simulator-first, mock-data-first, and local-validation-first. No PHI, company production data, or real regulated production integration is authorized by this register.
- Maturity statement: Environment registration is not implementation proof, production readiness, regulatory validation, or operational release.
- Review status: HUMAN ENVIRONMENT REVIEW REQUIRED

### ENV-011 - Automation, Historian, OT, Edge, and Device Witness

- Category: AUTOMATION AND OT ASSURANCE
- Strategic priority: **SUPPORTING REGULATED INFRASTRUCTURE**
- Commercialization track: AUTOMATION TRUTH ASSURANCE TRACK
- Primary assurance problem: Automation and OT evidence may be fragmented across PLCs, control systems, historians, edge devices, sensors, gateways, time sources, networks, and manual interventions.
- Key workflow dependencies: Controller identity; program version; recipe or setpoint; sensor identity; timestamp; historian ingestion; network state; edge state; alarm state; operator action; manual override; cybersecurity status; and backup or recovery state.
- Evidence sources: PLC or DCS events; historian records; sensor data; edge-device logs; configuration files; network logs; alarm histories; operator actions; cybersecurity evidence; backup evidence; and change records.
- Official source systems: DCS, SCADA, PLC platforms, historians, edge platforms, device-management systems, network systems, security platforms, MES, eQMS, and approved repositories.
- Human authority: Automation engineering, OT system owners, cybersecurity personnel, operations, maintenance, process engineering, validation personnel, and Quality Unit.
- Assurance outcomes: Automation truth assurance; historian-source agreement; trusted timestamp assurance; device identity integrity; manual-override visibility; edge witness integrity; and OT event reconstruction.
- Representative use cases: Historian gap; PLC-program mismatch; sensor identity conflict; edge-device witness; manual override; time-source drift; cybersecurity hold; and automation change verification.

**Architecture application**

- Platform A: Registers the use case, regulated context, stakeholders, risk classification, system inventory, and governance ownership.
- Platform B v1: Uses the frozen six-capability Platform B v1 core for registry, assurance checks, evidence upload, trust scoring, admissibility records, and wearable endpoint simulation where applicable.
- Platform B1 / MVP2: Evaluates advanced assurance conditions such as evidence integrity, workflow dependency integrity, source agreement, identity, authority, No-Bind state, reconstruction, and inspection readiness.
- Thread C / AEBOK: Translates verified lessons into Assurance Engineering doctrine, research, publications, teaching material, and regulated case studies.
- Thread D v1: May display or witness Platform B v1 assurance state through the locked Thread D v1 connector. It has no decision authority.
- Thread D2 / RAMAT Vision: May display Platform B1 evaluated assurance state through RAMAT Vision. It remains preview-only and DISPLAY / WITNESS ONLY.
- Cross-cutting Assurance OS: Uses shared identity, evidence integrity, hashing, rehashing, chain-of-custody, authority, provenance, and governance schemas.

**Mandatory boundaries**

- Decision boundary: Platform B or Platform B1 may evaluate assurance state. Qualified humans and authorized organizational roles make binding decisions.
- Display boundary: Thread D, Thread D2, RAMAT Vision, glasses, wearables, and device witnesses may display or witness state but may not approve, release, override, resolve, or execute regulated work.
- Source-of-truth boundary: Official records remain in governed source systems. COBIT-Chain may reference, hash, seal, evaluate, reconstruct, or display evidence but does not replace the official record.
- Data boundary: Simulator-first, mock-data-first, and local-validation-first. No PHI, company production data, or real regulated production integration is authorized by this register.
- Maturity statement: Environment registration is not implementation proof, production readiness, regulatory validation, or operational release.
- Review status: HUMAN ENVIRONMENT REVIEW REQUIRED

### ENV-012 - Regulatory Submission and AI-Native Inspection Readiness

- Category: REGULATORY AND INSPECTION ASSURANCE
- Strategic priority: **CORE LIFE-SCIENCES ASSURANCE**
- Commercialization track: REGULATORY AI INSPECTION PASSPORT TRACK
- Primary assurance problem: Static binders and disconnected evidence cannot reliably support human or AI-assisted regulatory inspection when claims, records, provenance, approvals, and current state disagree.
- Key workflow dependencies: Submission claim; supporting evidence; document version; source record; provenance; approval; change history; current state; inspection request; evidence package; cross-system consistency; and response accountability.
- Evidence sources: Submission documents; source records; review evidence; approvals; audit trails; change histories; validation evidence; data-integrity evidence; inspection responses; and connected evidence passports.
- Official source systems: Regulatory information management systems, document management systems, eQMS, clinical systems, laboratory systems, MES, ERP, and approved archival repositories.
- Human authority: Regulatory affairs, Quality Unit, subject-matter experts, legal or compliance personnel, submission owners, inspection coordinators, and authorized signatories.
- Assurance outcomes: Claim-to-proof traceability; submission provenance; inspection passport readiness; cross-system consistency; evidence reconstruction; AI-readable evidence; and accountable inspection response.
- Representative use cases: AI-generated submission content review; regulatory claim verification; inspection evidence passport; document-to-source mismatch; stale evidence; missing approval; and AI-assisted inspection reconstruction.

**Architecture application**

- Platform A: Registers the use case, regulated context, stakeholders, risk classification, system inventory, and governance ownership.
- Platform B v1: Uses the frozen six-capability Platform B v1 core for registry, assurance checks, evidence upload, trust scoring, admissibility records, and wearable endpoint simulation where applicable.
- Platform B1 / MVP2: Evaluates advanced assurance conditions such as evidence integrity, workflow dependency integrity, source agreement, identity, authority, No-Bind state, reconstruction, and inspection readiness.
- Thread C / AEBOK: Translates verified lessons into Assurance Engineering doctrine, research, publications, teaching material, and regulated case studies.
- Thread D v1: May display or witness Platform B v1 assurance state through the locked Thread D v1 connector. It has no decision authority.
- Thread D2 / RAMAT Vision: May display Platform B1 evaluated assurance state through RAMAT Vision. It remains preview-only and DISPLAY / WITNESS ONLY.
- Cross-cutting Assurance OS: Uses shared identity, evidence integrity, hashing, rehashing, chain-of-custody, authority, provenance, and governance schemas.

**Mandatory boundaries**

- Decision boundary: Platform B or Platform B1 may evaluate assurance state. Qualified humans and authorized organizational roles make binding decisions.
- Display boundary: Thread D, Thread D2, RAMAT Vision, glasses, wearables, and device witnesses may display or witness state but may not approve, release, override, resolve, or execute regulated work.
- Source-of-truth boundary: Official records remain in governed source systems. COBIT-Chain may reference, hash, seal, evaluate, reconstruct, or display evidence but does not replace the official record.
- Data boundary: Simulator-first, mock-data-first, and local-validation-first. No PHI, company production data, or real regulated production integration is authorized by this register.
- Maturity statement: Environment registration is not implementation proof, production readiness, regulatory validation, or operational release.
- Review status: HUMAN ENVIRONMENT REVIEW REQUIRED

### ENV-013 - Enterprise GxP IT, CMDB, Identity, ServiceNow, and Cybersecurity

- Category: ENTERPRISE GXP IT ASSURANCE
- Strategic priority: **SUPPORTING REGULATED INFRASTRUCTURE**
- Commercialization track: CITRUST AND ENTERPRISE ASSURANCE TRACK
- Primary assurance problem: Regulated applications and infrastructure may be operational while ownership, identity, privileged access, CMDB relationships, lifecycle, security, support, validation, or recovery evidence remains incomplete.
- Key workflow dependencies: Business application identity; infrastructure CI; owner; support group; lifecycle manager; AD or Entra identity; privileged access; myAccess approval; CyberArk; network rules; security monitoring; validation; backup; recovery; and retirement.
- Evidence sources: CMDB records; access requests; identity records; privileged-session evidence; security alerts; network evidence; configuration records; validation records; backup evidence; incidents; changes; and lifecycle records.
- Official source systems: ServiceNow, CMDB, Entra ID, Active Directory, CyberArk, myAccess, SIEM, network platforms, endpoint-management systems, validation repositories, and eQMS.
- Human authority: Application owner, system owner, infrastructure owner, lifecycle manager, cybersecurity personnel, access approvers, validation personnel, and Quality Unit.
- Assurance outcomes: CI identity assurance; owner and relationship integrity; access admissibility; privileged-action evidence; security-state assurance; lifecycle readiness; and defensible IT control reconstruction.
- Representative use cases: Manual Business Application CI creation; duplicate CI; CI deletion investigation; access approval; CyberArk route; orphaned CI; validation dependency; security-event evidence; and cutover readiness.

**Architecture application**

- Platform A: Registers the use case, regulated context, stakeholders, risk classification, system inventory, and governance ownership.
- Platform B v1: Uses the frozen six-capability Platform B v1 core for registry, assurance checks, evidence upload, trust scoring, admissibility records, and wearable endpoint simulation where applicable.
- Platform B1 / MVP2: Evaluates advanced assurance conditions such as evidence integrity, workflow dependency integrity, source agreement, identity, authority, No-Bind state, reconstruction, and inspection readiness.
- Thread C / AEBOK: Translates verified lessons into Assurance Engineering doctrine, research, publications, teaching material, and regulated case studies.
- Thread D v1: May display or witness Platform B v1 assurance state through the locked Thread D v1 connector. It has no decision authority.
- Thread D2 / RAMAT Vision: May display Platform B1 evaluated assurance state through RAMAT Vision. It remains preview-only and DISPLAY / WITNESS ONLY.
- Cross-cutting Assurance OS: Uses shared identity, evidence integrity, hashing, rehashing, chain-of-custody, authority, provenance, and governance schemas.

**Mandatory boundaries**

- Decision boundary: Platform B or Platform B1 may evaluate assurance state. Qualified humans and authorized organizational roles make binding decisions.
- Display boundary: Thread D, Thread D2, RAMAT Vision, glasses, wearables, and device witnesses may display or witness state but may not approve, release, override, resolve, or execute regulated work.
- Source-of-truth boundary: Official records remain in governed source systems. COBIT-Chain may reference, hash, seal, evaluate, reconstruct, or display evidence but does not replace the official record.
- Data boundary: Simulator-first, mock-data-first, and local-validation-first. No PHI, company production data, or real regulated production integration is authorized by this register.
- Maturity statement: Environment registration is not implementation proof, production readiness, regulatory validation, or operational release.
- Review status: HUMAN ENVIRONMENT REVIEW REQUIRED

### ENV-014 - Healthcare and Patient-Support AI

- Category: HEALTHCARE AI ASSURANCE
- Strategic priority: **FUTURE CONTROLLED EXTENSION**
- Commercialization track: HEALTHCARE ASSURANCE EXTENSION TRACK
- Primary assurance problem: AI-assisted healthcare and patient-support workflows may influence decisions without sufficient identity, evidence, authority, escalation, human accountability, or No-Bind controls.
- Key workflow dependencies: Patient identity; clinical context; model identity; approved use; data provenance; risk level; recommendation; clinician review; escalation; authority; documentation; communication; and adverse-event monitoring.
- Evidence sources: Model records; approved-use records; clinical context; recommendation records; human review; escalation records; communication evidence; audit trails; safety monitoring; and governance decisions.
- Official source systems: EHR, clinical decision-support systems, patient-support platforms, safety systems, quality systems, model registries, and governed clinical repositories.
- Human authority: Licensed clinician, medical authority, patient-safety personnel, privacy personnel, model owner, governance board, and authorized healthcare organization.
- Assurance outcomes: Authority-before-action; patient identity integrity; model-use admissibility; human accountability; escalation assurance; No-Bind governance; and defensible AI decision reconstruction.
- Representative use cases: AI recommendation requiring clinician review; unavailable approver; high-consequence recommendation hold; patient identity mismatch; model-use outside approved scope; and silent-alert governance.

**Architecture application**

- Platform A: Registers the use case, regulated context, stakeholders, risk classification, system inventory, and governance ownership.
- Platform B v1: Uses the frozen six-capability Platform B v1 core for registry, assurance checks, evidence upload, trust scoring, admissibility records, and wearable endpoint simulation where applicable.
- Platform B1 / MVP2: Evaluates advanced assurance conditions such as evidence integrity, workflow dependency integrity, source agreement, identity, authority, No-Bind state, reconstruction, and inspection readiness.
- Thread C / AEBOK: Translates verified lessons into Assurance Engineering doctrine, research, publications, teaching material, and regulated case studies.
- Thread D v1: May display or witness Platform B v1 assurance state through the locked Thread D v1 connector. It has no decision authority.
- Thread D2 / RAMAT Vision: May display Platform B1 evaluated assurance state through RAMAT Vision. It remains preview-only and DISPLAY / WITNESS ONLY.
- Cross-cutting Assurance OS: Uses shared identity, evidence integrity, hashing, rehashing, chain-of-custody, authority, provenance, and governance schemas.

**Mandatory boundaries**

- Decision boundary: Platform B or Platform B1 may evaluate assurance state. Qualified humans and authorized organizational roles make binding decisions.
- Display boundary: Thread D, Thread D2, RAMAT Vision, glasses, wearables, and device witnesses may display or witness state but may not approve, release, override, resolve, or execute regulated work.
- Source-of-truth boundary: Official records remain in governed source systems. COBIT-Chain may reference, hash, seal, evaluate, reconstruct, or display evidence but does not replace the official record.
- Data boundary: Simulator-first, mock-data-first, and local-validation-first. No PHI, company production data, or real regulated production integration is authorized by this register.
- Maturity statement: Environment registration is not implementation proof, production readiness, regulatory validation, or operational release.
- Review status: HUMAN ENVIRONMENT REVIEW REQUIRED

## Step 152 review gate

Before Step 152 begins, review all 14 environments, confirm the strategic-priority assignments, verify the official source systems, confirm the human authority roles, and verify that no environment grants approval, release, execution, override, or source-of-truth authority to Thread D, Thread D2, RAMAT Vision, glasses, wearables, or device witnesses.

Step 152 will create the Cross-Industry Assurance Pack Register. It must preserve the life-sciences core and the architecture boundaries established through Steps 149, 150, and 151.

**STEP 151 LIFE-SCIENCES ASSURANCE ENVIRONMENT REGISTER COMPLETE**

**STEP 152: READY AFTER REVIEW**

